105 related articles for article (PubMed ID: 27115884)
21. Demystifying Sacral Masses: A Pictorial Review.
Senne J; Nguyen V; Staner D; Stensby JD; Bhat AP
Indian J Radiol Imaging; 2021 Jan; 31(1):185-192. PubMed ID: 34316126
[TBL] [Abstract][Full Text] [Related]
22. A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.
Martin E; Geitenbeek RTJ; Coert JH; Hanff DF; Graven LH; Grünhagen DJ; Verhoef C; Taal W
Neuro Oncol; 2021 Apr; 23(4):557-571. PubMed ID: 33326583
[TBL] [Abstract][Full Text] [Related]
23. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
Linke C; Wösle M; Harder A
BMC Cancer; 2020 Sep; 20(1):896. PubMed ID: 32948135
[TBL] [Abstract][Full Text] [Related]
24. How Effective Are Noninvasive Tests for Diagnosing Malignant Peripheral Nerve Sheath Tumors in Patients with Neurofibromatosis Type 1? Diagnosing MPNST in NF1 Patients.
Schwabe M; Spiridonov S; Yanik EL; Jennings JW; Hillen T; Ponisio M; McDonald DJ; Dehdashti F; Cipriano CA
Sarcoma; 2019; 2019():4627521. PubMed ID: 31354382
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.
Reinert CP; Schuhmann MU; Bender B; Gugel I; la Fougère C; Schäfer J; Gatidis S
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):776-787. PubMed ID: 30535768
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted imaging and diffusion tensor imaging as adjuncts to conventional MRI for the diagnosis and management of peripheral nerve sheath tumors: current perspectives and future directions.
Mazal AT; Ashikyan O; Cheng J; Le LQ; Chhabra A
Eur Radiol; 2019 Aug; 29(8):4123-4132. PubMed ID: 30535638
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.
Well L; Salamon J; Kaul MG; Farschtschi S; Herrmann J; Geier KI; Hagel C; Bockhorn M; Bannas P; Adam G; Mautner VF; Derlin T
Neuro Oncol; 2019 Mar; 21(4):508-516. PubMed ID: 30496452
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Imaging and Management of Common Intra-articular and Peri-articular Soft Tissue Tumors and Tumorlike Conditions of the Knee.
Evenski AJ; Stensby JD; Rosas S; Emory CL
J Knee Surg; 2019 Apr; 32(4):322-330. PubMed ID: 30449023
[TBL] [Abstract][Full Text] [Related]
29. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.
Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC
J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847
[TBL] [Abstract][Full Text] [Related]
30. Plexiform neurofibroma causing an ossifying subperiosteal haematoma: a rare case in the tibia of an 11-year-old girl.
Lavell A; Jones CW; Wong D; Counsel P; Carey-Smith R
Skeletal Radiol; 2017 Oct; 46(10):1405-1413. PubMed ID: 28623408
[TBL] [Abstract][Full Text] [Related]
31. Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies.
Kim A; Stewart DR; Reilly KM; Viskochil D; Miettinen MM; Widemann BC
Sarcoma; 2017; 2017():7429697. PubMed ID: 28592921
[TBL] [Abstract][Full Text] [Related]
32. The Role of [
Tovmassian D; Abdul Razak M; London K
Int J Surg Oncol; 2016; 2016():6162182. PubMed ID: 28058117
[No Abstract] [Full Text] [Related]
33. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
35. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
36. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.
Broski SM; Johnson GB; Howe BM; Nathan MA; Wenger DE; Spinner RJ; Amrami KK
Skeletal Radiol; 2016 Aug; 45(8):1097-105. PubMed ID: 27115884
[TBL] [Abstract][Full Text] [Related]
38. FDG PET/CT and MRI Features of Pathologically Proven Schwannomas.
Dewey BJ; Howe BM; Spinner RJ; Johnson GB; Nathan MA; Wenger DE; Broski SM
Clin Nucl Med; 2021 Apr; 46(4):289-296. PubMed ID: 33443952
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
